Quadruplet regimen for newly diagnosed multiple myeloma is effective in the standard-risk subgroup but not in the high-risk subgroup.

Frontiers in pharmacology(2024)

引用 0|浏览0
暂无评分
关键词
quadruplet regimen,newly-diagnosed,multiple myeloma,standard risk,high risk
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要